Presbitero Aguirre Vargas, DO, P A | |
Comunidad Aguilita # 158 Calle Correa, Juana Diaz, PR 00795-9844 | |
(787) 718-3938 | |
Not Available |
Full Name | Presbitero Aguirre Vargas |
---|---|
Gender | Male |
Speciality | Assistant, Podiatric |
Location | Comunidad Aguilita # 158 Calle Correa, Juana Diaz, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538717467 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Presbitero Aguirre Vargas, DO, P A Hc 4 Box 8168, Juana Diaz, PR 00795-9844 Ph: (787) 718-3938 | Presbitero Aguirre Vargas, DO, P A Comunidad Aguilita # 158 Calle Correa, Juana Diaz, PR 00795-9844 Ph: (787) 718-3938 |
News Archive
Scientists at Dana-Farber Cancer Institute and the Broad Institute have found strikingly high levels of a bacterium in colorectal cancers, a sign that it might contribute to the disease and potentially be a key to diagnosing, preventing, and treating it.
Research at Johns Hopkins suggests that if hospitals would show physicians the price of some diagnostic laboratory tests at the time the tests are ordered, doctors would order substantially fewer of them or search for lower-priced alternatives.
A leading international biotechnology company has selected ReadSoft's SAP-certified invoice processing solution to process paper and electronic invoices in North America. After implementing SAP more than a year ago, the company now wanted to automate its invoice processing. ReadSoft was chosen because of its proven expertise from similar implementations in SAP environments. The deal was signed during the third quarter of 2010.
Cochlear Limited, the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration approval of three new products to its suite of hearing technology solutions.
Indiana University School of Medicine researchers are participating in the Rare and Atypical Diabetes Network (RADIANT), a nationwide study funded by the National Institutes of Health. The study seeks to discover new forms of diabetes, identify their causes, and understand how they differ from more common types of diabetes.
› Verified 3 days ago